Back to search

National and Kapodistrian University of Athens

Μελέτη του επιπολασμού της λοίμωξης από τον ιό της ηπατίτιδας C σε πληθυσμό εγκύων γυναικών και διερεύνηση της μετάδοσης του ιού από τη μητέρα στο παιδί

Abstract

dc:description

The objective of this paper was assess the prevalence of anti-HCV and the rate of vertical transmission of hepatitis C virus in a random sample of pregnant women. 5.120 pregnant women attending the “Helena Venizelou” Maternity Hospital were screened for HCV antibodies by ELISA 2 and RIBA 2 methods. Anti-HCV positive women were also tested for anti-HIV antibodies and HCV RNA. Anti-HCV positive women together with an anti-HCV negative group were interviewed to collect epidemiological data. In 22 infants of 21 anti-HCV positive, anti-HIV negative mothers (1 set of twins), HCV RNA analyses by polymerase chain reaction (PCR) was performed on 3 blood samples from birth to 12 months of age (0,6,12 months). The overall anti-HCV prevalence in the pregnant women was 0,66% (34/5120). This figures is in agreement with the available data on blood donors in Greece and on healthy population in the Mediterranean area. HCV seropositivity is positively related by the transfusions and the drug abuse and negatively by the socioeconomical level. Regarding the risk factors identified in the study group, 11,8% of the anti-HCV positive women had received in the past a blood transfusion, and 11,8% at them were drug users. None of the known risk factors was identified in the 76.7% of the anti-HCV positive women. The risk of HCV vertical transmission in this study was relatively low (4,76%), probably because the sample was drawn from a low risk population. The risk of HCV vertical transmission in viremic women was higher, 7,69%. In conclusion, considering that: · HCV infection is a very serious public health issue worldwide. · The risk of HCV vertical transmission is low but non insignificant even in low-risk pregnant women. · In a considerable proportion of the anti-HCV positive women none of the known risk factors were present; We could propose that: · The prenatal anti-HCV screening to all pregnant women even those not in high-risk groups. · Infant screening born by anti-HCV positive, anti-HIV negative women could be limited in the anti-HCV detection after the first year of life. · Screening of infants born to viremic mothers should take place before their first birthday and be extend to HCV RNA detection.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2000

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Farmaki, Georgia
  • Φαρμάκη, Γεωργία

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/21616

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Farmaki, Georgia; Φαρμάκη, Γεωργία. Μελέτη του επιπολασμού της λοίμωξης από τον ιό της ηπατίτιδας C σε πληθυσμό εγκύων γυναικών και διερεύνηση της μετάδοσης του ιού από τη μητέρα στο παιδί. National and Kapodistrian University of Athens, 2000. http://hdl.handle.net/10442/hedi/21616